CRINETICS PHARMACEUTICALS, INC. (CRNX)
Clinical trial NCT06712823 updates: 1. completion date: 2027-11-01 → 2029-08-01 2. primary completion date: 2027-11-01 → 2029-07-01 3. enrollment: 150 → 200 participants
Clinical trial NCT06712823 updates: 1. completion date: 2027-11-01 → 2029-08-01 2. primary completion date: 2027-11-01 → 2029-07-01 3. enrollment: 150 → 200 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical